These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

618 related items for PubMed ID: 22595973

  • 21. Clinical and economic impact of the taurolidine lock on home parenteral nutrition.
    Arnoriaga Rodríguez M, Pérez de Ciriza Cordeu M, Camblor Álvarez M, Bretón Lesmes I, Motilla de la Cámara M, Velasco Gimeno C, Arhip L, García Peris P, Cuerda Compés C.
    Nutr Hosp; 2018 Jun 28; 35(4):761-766. PubMed ID: 30070861
    [Abstract] [Full Text] [Related]

  • 22. Catheter salvage or removal in catheter-related bloodstream infections with Staphylococcus aureus in children with chronic intestinal failure receiving home parenteral nutrition and the use of prophylactic taurolidine catheter lock solution: A descriptive cohort study.
    Demirok A, Illy DHC, Nagelkerke SQ, Lagerweij MF, Benninga MA, Tabbers MM.
    JPEN J Parenter Enteral Nutr; 2024 May 28; 48(4):486-494. PubMed ID: 38605559
    [Abstract] [Full Text] [Related]

  • 23. Response to Olthof et al.
    Klek S, Szczepanek K.
    JPEN J Parenter Enteral Nutr; 2015 May 28; 39(4):385-6. PubMed ID: 25883236
    [No Abstract] [Full Text] [Related]

  • 24. Taurolidine lock is superior to heparin lock in the prevention of catheter related bloodstream infections and occlusions.
    Olthof ED, Versleijen MW, Huisman-de Waal G, Feuth T, Kievit W, Wanten GJ.
    PLoS One; 2014 May 28; 9(11):e111216. PubMed ID: 25379781
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Taurolidine 2% as an antimicrobial lock solution for prevention of recurrent catheter-related bloodstream infections.
    Jurewitsch B, Lee T, Park J, Jeejeebhoy K.
    JPEN J Parenter Enteral Nutr; 1998 May 28; 22(4):242-4. PubMed ID: 9661127
    [Abstract] [Full Text] [Related]

  • 27. Ethanol lock therapy in reducing catheter-related bloodstream infections in adult home parenteral nutrition patients: results of a retrospective study.
    John BK, Khan MA, Speerhas R, Rhoda K, Hamilton C, Dechicco R, Lopez R, Steiger E, Kirby DF.
    JPEN J Parenter Enteral Nutr; 2012 Sep 28; 36(5):603-10. PubMed ID: 22205580
    [Abstract] [Full Text] [Related]

  • 28. Absence of microbial adaptation to taurolidine in patients on home parenteral nutrition who develop catheter related bloodstream infections and use taurolidine locks.
    Olthof ED, Rentenaar RJ, Rijs AJ, Wanten GJ.
    Clin Nutr; 2013 Aug 28; 32(4):538-42. PubMed ID: 23267744
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Microbiocidal effects of various taurolidine containing catheter lock solutions.
    Olthof ED, Nijland R, Gülich AF, Wanten GJ.
    Clin Nutr; 2015 Apr 28; 34(2):309-14. PubMed ID: 24861410
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Observational study of need for thrombolytic therapy and incidence of bacteremia using taurolidine-citrate-heparin, taurolidine-citrate and heparin catheter locks in patients treated with hemodialysis.
    Solomon LR, Cheesbrough JS, Bhargava R, Mitsides N, Heap M, Green G, Diggle P.
    Semin Dial; 2012 Apr 28; 25(2):233-8. PubMed ID: 21916999
    [Abstract] [Full Text] [Related]

  • 34. A randomized double-blind controlled trial of taurolidine-citrate catheter locks for the prevention of bacteremia in patients treated with hemodialysis.
    Solomon LR, Cheesbrough JS, Ebah L, Al-Sayed T, Heap M, Millband N, Waterhouse D, Mitra S, Curry A, Saxena R, Bhat R, Schulz M, Diggle P.
    Am J Kidney Dis; 2010 Jun 28; 55(6):1060-8. PubMed ID: 20207458
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Comparison of ML8-X10 (a prototype oil-in-water micro-emulsion based on a novel free fatty acid), taurolidine/citrate/heparin and vancomycin/heparin antimicrobial lock solutions in the eradication of biofilm-producing staphylococci from central venous catheters.
    Luther MK, Mermel LA, LaPlante KL.
    J Antimicrob Chemother; 2014 Dec 28; 69(12):3263-7. PubMed ID: 25096074
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 31.